CLEOCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cleocin, and when can generic versions of Cleocin launch?
Cleocin is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in fourteen NDAs.
The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin
A generic version of CLEOCIN was approved as clindamycin palmitate hydrochloride by PADAGIS US on July 7th, 2010.
Summary for CLEOCIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 11 |
Patent Applications: | 4,257 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CLEOCIN |
Drug Sales Revenues: | Drug sales revenues for CLEOCIN |
What excipients (inactive ingredients) are in CLEOCIN? | CLEOCIN excipients list |
DailyMed Link: | CLEOCIN at DailyMed |
Recent Clinical Trials for CLEOCIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
University of California, Los Angeles | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
Pharmacology for CLEOCIN
Drug Class | Lincosamide Antibacterial |
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLEOCIN
US Patents and Regulatory Information for CLEOCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | CLEOCIN | clindamycin hydrochloride | CAPSULE;ORAL | 061809-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CLEOCIN T | clindamycin phosphate | GEL;TOPICAL | 050615-001 | Jan 7, 1987 | AB1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767-001 | Aug 13, 1999 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CLEOCIN | clindamycin phosphate | CREAM;VAGINAL | 050680-002 | Mar 2, 1998 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | CLEOCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 062803-001 | Oct 16, 1987 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CLEOCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767-001 | Aug 13, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CLEOCIN
See the table below for patents covering CLEOCIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 1200065 | ⤷ Try a Trial | |
Mexico | PA02001320 | COMPOSICION INTRAVAGINAL DE CLINDAMICINA EN FORMA DE OVULO. (INTRAVAGINAL CLINDAMYCIN OVULE COMPOSITION.) | ⤷ Try a Trial |
Spain | 2207532 | ⤷ Try a Trial | |
Canada | 2378572 | ⤷ Try a Trial | |
Australia | 768907 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CLEOCIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | 2013/044 | Ireland | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
1304992 | PA2013025,C1304992 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
1304992 | C01304992/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
1304992 | 122013000081 | Germany | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322 |
1304992 | 92401 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |